Balanced news tone
News Sentiment
4552 sentiment intelligence
JCR Pharmaceuticals Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
71/100 classification confidence.
directly relevant articles
high-authority source matches
+4.8% over one week, +6.2% over four weeks, trend inactive, and below fair value.
RBC Downgrades Telix Pharmaceuticals to Sector Perform From Outperform, Keeps AU$18 Price Target
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
RBC Downgrades Telix Pharmaceuticals to Sector Perform From Outperform, Keeps AU$18 Price Target
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 17 Jul 2026 10:26
- Source
- MT Newswires
JCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:00
- Source
- TipRanks
Price to sales forward of JCR Pharmaceuticals Co., Ltd. – FWB:JCR
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 09:28
- Source
- TradingView
Price to book forward of JCR Pharmaceuticals Co., Ltd. – TSE:4552
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 00:29
- Source
- TradingView